These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 7702643)
21. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. Pratt PF; Hillard CJ; Edgemond WS; Campbell WB Am J Physiol; 1998 Jan; 274(1):H375-81. PubMed ID: 9458889 [TBL] [Abstract][Full Text] [Related]
22. Potential biosynthetic connections between the two cannabimimetic eicosanoids, anandamide and 2-arachidonoyl-glycerol, in mouse neuroblastoma cells. Di Marzo V; De Petrocellis L; Sugiura T; Waku K Biochem Biophys Res Commun; 1996 Oct; 227(1):281-8. PubMed ID: 8858137 [TBL] [Abstract][Full Text] [Related]
23. Ontogenetic development of the response to anandamide and delta 9-tetrahydrocannabinol in mice. Fride E; Mechoulam R Brain Res Dev Brain Res; 1996 Aug; 95(1):131-4. PubMed ID: 8873985 [TBL] [Abstract][Full Text] [Related]
24. The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide. O'Sullivan SE; Kendall DA; Randall MD Br J Pharmacol; 2005 Jun; 145(4):514-26. PubMed ID: 15821751 [TBL] [Abstract][Full Text] [Related]
25. Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta. O'Sullivan SE; Kendall DA; Randall MD Eur J Pharmacol; 2005 Jan; 507(1-3):211-21. PubMed ID: 15659311 [TBL] [Abstract][Full Text] [Related]
26. Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans. Thieme U; Schelling G; Hauer D; Greif R; Dame T; Laubender RP; Bernhard W; Thieme D; Campolongo P; Theiler L Drug Test Anal; 2014; 6(1-2):17-23. PubMed ID: 24424856 [TBL] [Abstract][Full Text] [Related]
27. Pancreatic islet arachidonic acid turnover and metabolism and insulin release in response to delta-9-tetrahydrocannabinol. Laychock SG; Hoffman JM; Meisel E; Bilgin S Biochem Pharmacol; 1986 Jun; 35(12):2003-8. PubMed ID: 3013206 [TBL] [Abstract][Full Text] [Related]
29. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice. Walentiny DM; Vann RE; Wiley JL Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527 [TBL] [Abstract][Full Text] [Related]
30. Biosynthesis and turnover of anandamide and other N-acylethanolamines in peritoneal macrophages. Kuwae T; Shiota Y; Schmid PC; Krebsbach R; Schmid HH FEBS Lett; 1999 Oct; 459(1):123-7. PubMed ID: 10508930 [TBL] [Abstract][Full Text] [Related]
31. A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes. Rockwell CE; Kaminski NE J Pharmacol Exp Ther; 2004 Nov; 311(2):683-90. PubMed ID: 15284281 [TBL] [Abstract][Full Text] [Related]
32. A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats. Wiley JL; LaVecchia KL; Karp NE; Kulasegram S; Mahadevan A; Razdan RK; Martin BR Exp Clin Psychopharmacol; 2004 Aug; 12(3):173-9. PubMed ID: 15301634 [TBL] [Abstract][Full Text] [Related]
33. Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma 'anandamide amidohydrolase'. Maurelli S; Bisogno T; De Petrocellis L; Di Luccia A; Marino G; Di Marzo V FEBS Lett; 1995 Dec; 377(1):82-6. PubMed ID: 8543025 [TBL] [Abstract][Full Text] [Related]
34. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics. Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167 [TBL] [Abstract][Full Text] [Related]
35. Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors. Eisenstein TK; Meissler JJ; Wilson Q; Gaughan JP; Adler MW J Neuroimmunol; 2007 Sep; 189(1-2):17-22. PubMed ID: 17640739 [TBL] [Abstract][Full Text] [Related]
36. Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide. Houser SJ; Eads M; Embrey JP; Welch SP Brain Res; 2000 Feb; 857(1-2):337-42. PubMed ID: 10700588 [TBL] [Abstract][Full Text] [Related]
37. A comparison of delta 9-THC and anandamide induced c-fos expression in the rat forebrain. McGregor IS; Arnold JC; Weber MF; Topple AN; Hunt GE Brain Res; 1998 Aug; 802(1-2):19-26. PubMed ID: 9748483 [TBL] [Abstract][Full Text] [Related]
38. Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina. Bisogno T; Delton-Vandenbroucke I; Milone A; Lagarde M; Di Marzo V Arch Biochem Biophys; 1999 Oct; 370(2):300-7. PubMed ID: 10577359 [TBL] [Abstract][Full Text] [Related]
39. The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. Wartmann M; Campbell D; Subramanian A; Burstein SH; Davis RJ FEBS Lett; 1995 Feb; 359(2-3):133-6. PubMed ID: 7867785 [TBL] [Abstract][Full Text] [Related]
40. Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide. Solinas M; Scherma M; Tanda G; Wertheim CE; Fratta W; Goldberg SR J Pharmacol Exp Ther; 2007 Jun; 321(3):1127-34. PubMed ID: 17351107 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]